Eylea - International Biopharmaceutical Industry

Current Edition

news

Kodiak crashes on negative trial results for would-be Eylea competitor

Dive Brief: Shares in Kodiak Sciences plummeted by 80% in Wednesday morning trading, erasing about $2 billion in market value, after the biotech company's experime...

24 February 2022 news Eylea | Kodiak

Continue Reading →

news

New data bolster Regeneron’s plan to defend top-selling eye drug

While drugs like Eylea can be life-changing for patients facing the prospect of vision loss, injections in the eye are unpleasant and the possibility of extending the...

27 August 2021 news eye drug | Eylea

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Kodiak crashes on negative trial results for would-be Eylea competitor

New data bolster Regeneron’s plan to defend top-selling eye drug

International Biopharmaceutical Industry